ArticleFrontiers in public health2026
Exposure to per- and poly-fluoroalkyl substances and associations with embryo quality and adverse pregnancy outcomes: a prospective cohort study.
Article in Frontiers in public health, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Identification of Inflammatory Markers for the Prediction and Diagnosis of Diminished Ovarian Reserve Using Olink Targeted Proteomics.Journal of clinical medicine · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Per- and poly-fluoroalkyl substances (PFASs) are a group of synthetized industrial pollutants which have been detected worldwide in both environment and humans and gradually raised public health concerns. Previous studies suggested that PFASs had reproductive toxicity and may do harm to pregnancy and children. However, it is still uncertain that whether effect of PFAS exposure on offsprings begins from embryo quality or post-implantation pregnancy outcomes. This study explores the association between exposure to PFASs and embryo quality or pregnancy outcomes to promote maternal-infant health. Methods: This study included 246 women who underwent their first Results: PFAS exposure had no significant association with high-quality blastocyst rate. Whereas, PFAS exposure had significantly adverse effect on miscarriage and live birth rate with the predominant risk of perfluoro-n-butanoic acid (PFBA) (For miscarriage, Q4 vs. Q1 OR: 6.44 (95%CI: 1.47, 33.72), Adjusted Conclusion: For women undergoing IVF/ICSI, exposure to PFASs was associated with higher miscarriage and lower live birth rate but had no adverse effect on embryo quality.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.